Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 64

Sort by

Sort Order Select

Journal Articles

Impact of HLA Class I Allele Mismatch on Viral Infection within 100 Days after Cord Blood Transplantation

Tomoki Iemura, MD, Yasuyuki Arai, MD PhD, Junya Kanda, MD, Toshio Kitawaki, MD PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Kouhei Yamashita, MD PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2019) 134 (Supplement_1): 3267.

https://doi.org/10.1182/blood-2019-123073

Published: 2019

Journal Articles

Simulated Treatment Comparison (STC) of Human Mesenchymal Stromal Cells (Remestemcel-L, REM) and Ruxolitinib (RUX) for Steroid-Refractory Acute Graft-Versus-Host Disease (SR aGVHD) Pediatric Patients

Tracy Westley, MPH, Dimitrios Tomaras, MSc, Eric Strati, PharmD, Donna Skerrett, MD MS, Anna Forsythe, PharmD, MBA, MMSc, Gabriel Tremblay, DBA, MSc, BS

Blood (2019) 134 (Supplement_1): 4545.

https://doi.org/10.1182/blood-2019-131098

Published: 2019

Journal Articles

Targeting Transcriptional Co-Activator PGC-1a for the Treatment of Sickle Cell Disease

Alawi Habara, MBBS, MSc, Cuong LE, PhD, David H.K. Chui, MD, Martin H. Steinberg, MD, Shuaiying Cui, PhD

Blood (2019) 134 (Supplement_1): 2254.

https://doi.org/10.1182/blood-2019-123959

Published: 2019

Journal Articles

Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient

Blood (2019) 134 (Supplement_1): 1944.

https://doi.org/10.1182/blood-2019-125276

Published: 2019

Journal Articles

Long-Term Outcome of Children with Acute Leukemia (AL) Given Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT)

Pietro Merli, MD, Daria Pagliara, MD PhD, Mattia Algeri, MD, Federica Galaverna, MD, Giuseppina Li Pira, PhD, Valentina Bertaina, PhD, Mauro Montanari, MD, Giovanna Leone, MD, Stefania Gaspari, MD, Michele Massa, MD, Valentina Cirillo, PhD, Maria Giuseppina Cefalo, MD, Simone Biagini, MSc, Marco Becilli, MD, Elia Girolami, MSc, Roberto Carta, MD, Annalisa Ruggeri, MD, Franco Locatelli, MD PhD

Blood (2019) 134 (Supplement_1): 799.

https://doi.org/10.1182/blood-2019-128416

Published: 2019

Journal Articles

Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Blood (2018) 132 (Supplement 1): 896.

https://doi.org/10.1182/blood-2018-99-111356

Published: 2018

Journal Articles

Regulating Transcriptional Co-Activator PGC-1α for the Treatment of Sickle Cell Disease

Alawi Habara, MBBS, MSc, Cuong LE, PhD, George J Murphy, PhD, David H.K. Chui, MD, Martin H. Steinberg, MD, Shuaiying Cui, PhD

Blood (2018) 132 (Supplement 1): 2358.

https://doi.org/10.1182/blood-2018-99-111022

Published: 2018

Journal Articles

Reduced Toxicity Conditioning Is Better Tolerated but Has Higher Graft Failure Compared to Myeloablative Conditioning in Children with Inherited Metabolic Disorders

Michael Downey, BA, Ashish O. Gupta, MBBS, MPH, Ryan Shanley, M.S, Weston P. Miller, MD, Paul Orchard, MD, Angela R. Smith, MD MS

Blood (2018) 132 (Supplement 1): 3352.

https://doi.org/10.1182/blood-2018-99-117573

Published: 2018

Journal Articles

Hyper-CVAD Plus Ofatumumab As Frontline Therapy in CD20+ Acute Lymphoblastic Leukemia: Updated Results of a Phase II Trial

Blood (2017) 130 (Supplement 1): 3876.

https://doi.org/10.1182/blood.V130.Suppl_1.3876.3876

Published: 2017

Journal Articles

Nicord Single Unit Expanded Umbilical Cord Blood Transplantation: Final Results of a Multicenter Phase I/ II Trial

Mitchell E. Horwitz, MD, Daniela Cilloni, MD, David Valcarcel, Francesco Frassoni, MD, Jaap Jan Boelens, MD PhD, Madan Jagasia, MD MBBS, MS, John E. Wagner, MD, Jurgen Kuball, MD, Liang Piu Koh, Navneet S. Majhail, MD MS, Patrick J. Stiff, MD, Rabi Hanna, MD, Richard Thomas T. Maziarz, MD, William YK Hwang, MBBS, FRCP, Pau Montesinos, MD PhD, Joanne Kurtzberg, MD, Guillermo Sanz, MD

Blood (2017) 130 (Supplement 1): 847.

https://doi.org/10.1182/blood.V130.Suppl_1.847.847

Published: 2017

Journal Articles

Adoptive Immunotherapy with Cord Blood (CB) Grafts Targeting Shared Inherited Paternal Antigens (IPA) and/or Non-Inherited Maternal Antigens (NIMA) during Induction Treatment for High Risk Myeloid Malignancies: Safety and Preliminary Results

Usama Gergis, MD, Koen Van Besien, MD PhD, Emeline Masson Frenet, PhD, Tsiporah B. Shore, MD, Sebastian A. Mayer, MD, Adrienne A. Phillips, MD MPH, Jingmei Hsu, MD PhD, Gail J. Roboz, MD, Ellen K Ritchie, MD, Joseph Scandura, MDPhD, Sangmin Lee, MD, Pinkal Desai, MDMPH, Michael Samuel, MD, Jeffrey Ball, MD, Maria S. Albano, PhD, Rodica Ciubotariu, MD PhD, Ludy Dobrila, PhD, Cynthia Romeo, PhD, Andromachi Scaradavou, MD

Blood (2017) 130 (Supplement 1): 2627.

https://doi.org/10.1182/blood.V130.Suppl_1.2627.2627

Published: 2017

Journal Articles

Blinatumomab in B-Cell Acute Lymphoblastic Leukemia with Positive Minimal Residual Disease: Initial Results of a Phase II Trial

Abhishek Maiti, MBBS, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Maria Khouri, Koichi Takahashi, MD, Maro Ohanian, DO, Gautam Borthakur, MD, Marina Konopleva, MD PhD, Naval Daver, MD, Zeev Estrov, MD, Yesid Alvarado, MD, Philip A Thompson, MBBS, Nitin Jain, MD, Farhad Ravandi, MBBS, Guillermo Garcia-Manero, MD, Carissa N Cholick, Rita Khouri, Susan M. O'Brien, MD, Elias J. Jabbour, MD

Blood (2017) 130 (Supplement 1): 5038.

https://doi.org/10.1182/blood.V130.Suppl_1.5038.5038

Published: 2017

Journal Articles

High-Exposure, Targeted Daily Busulfan and Fludarabine-Based Conditioning for Children Undergoing Hematopoietic Stem Cell Transplantation for Inherited Metabolic Disorders: Outcomes at a Single Center

Weston P Miller, Melisa Kay Stricherz, PharmD, Cathryn Jennissen, PharmD, Nicole Sando, Jennifer Danielson, Troy Lund, Paul J Orchard

Blood (2016) 128 (22): 2191.

https://doi.org/10.1182/blood.V128.22.2191.2191

Published: 2016

Journal Articles

The Changing Patterns of Graft Failure in MPS1H, Hurler Syndrome: A Review of 30-Years Experience

Su Han Lum, Weston P Miller, Simon Jones, Jean Mercer, Troy Lund, Denise Bonney, Paul J Orchard, Robert Wynn

Blood (2016) 128 (22): 4700.

https://doi.org/10.1182/blood.V128.22.4700.4700

Published: 2016

Journal Articles

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Judith Feucht, Kathrin Opherk, Peter Lang, Simone Kayser, Lena Hartl, Wolfgang Bethge, Susanne Matthes-Martin, Peter Bader, Michael H. Albert, Britta Maecker-Kolhoff, Johann Greil, Hermann Einsele, Paul-Gerhardt Schlegel, Friedhelm R. Schuster, Bernhard Kremens, Claudia Rossig, Bernd Gruhn, Rupert Handgretinger, Tobias Feuchtinger

Blood (2015) 125 (12): 1986–1994.

https://doi.org/10.1182/blood-2014-06-573725

Published: 2015

Includes: Supplemental data

Journal Articles

Banked, GMP Grade Third Party T-Cell Lines Specific for CMVpp65 Epitopes Presented By Certain Prevalent HLA Alleles More Consistently Clear CMV Infections in a Genetically Heterogeneous Population of HSCT Recipients

Aisha N. Hasan, MD, Susan E. Prockop, MD, Guenther Koehne, MD PhD, Ekaterina Doubrovina, MD PhD, Richard J. O'Reilly, MD

Blood (2014) 124 (21): 309.

https://doi.org/10.1182/blood.V124.21.309.309

Published: 2014

Journal Articles

Transient Bcl-XL Overexpression in Donor Stem Cells Increases Efficacy of Hematopoietic Stem Cell Transplantation without Increasing the Risk of Leukemogenesis

Miriam Erlacher, MDPhD, Matthias Kollek, Gesina Voigt, Daniela Bertele, Dr, Felix Krombholz, Stefan Schiller, PhD, Ana Garcia-Saez, PhD, Stephan Geley, MD, Andreas Villunger, PhD, Charlotte M Niemeyer, MD

Blood (2014) 124 (21): 4350.

https://doi.org/10.1182/blood.V124.21.4350.4350

Published: 2014

Journal Articles

Infectious Complications After Unrelated Donor Allogeneic Hematopoietic Cell Transplantation With Or Without Alemtuzumab Based In Vivo Lymphocyte Depletion

Brian C. Shaffer, MD, Andrew Flynn, David Moorshead, Zach Powell, Jennifer Hsu, RN, Rachel B Salit, MD, Frances T. Hakim, PhD, Ronald E. Gress, MD, Michael Bishop, MD, Juan Gea-Banacloche, MD, Steven Z. Pavletic, MD

Blood (2013) 122 (21): 4580.

https://doi.org/10.1182/blood.V122.21.4580.4580

Published: 2013

Journal Articles

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning Leads To High Rates Of Long-Term Engraftment and Low Toxicity Enabling The Use Of Mismatched and Unrelated Donors For Transplantation In Haemoglobinopathies

Josu de la Fuente, PhD, FRCP, MRCPCH, FRCPath, Farah O'Boyle, PhD, Yvonne Harrington, RCN, Nancy O'Brien, RCN, Natalie Killeen, Subarna Chakravorty, PhD, FRCPath, MRCPCH, Leena Karnik, FRCPath, Richard Szydlo, PhD, Irene Roberts, MD FRCP FRCPCH FRCPath

Blood (2013) 122 (21): 2041.

https://doi.org/10.1182/blood.V122.21.2041.2041

Published: 2013

Journal Articles

The Effectiveness Of Cidofovir In Disseminated Adenovirus Infections After Pediatric HSCT Is Closely Related To Lymphocyte Reconstitution

Gertjan Lugthart, MD, Marloes A. Oomen, BSc, Cornelia M. Jol-van der Zijde, Lynne M. Ball, FRCP, FRCPath, MD, FRCPCH, Dorine Bresters, MD, PhD, Wouter J.W. Kollen, MD, PhD, Frans J. Smiers, MD, PhD, Clementien L. Vermont, MD, PhD, Robbert G.M. Bredius, MD, PhD, Marco W. Schilham, PhD, Maarten J.D. van Tol, PhD, Arjan C. Lankester, MD, PhD

Blood (2013) 122 (21): 3292.

https://doi.org/10.1182/blood.V122.21.3292.3292

Published: 2013

NARROW

Impact of HLA Class I Allele Mismatch on Viral Infection within 100 Days after Cord Blood Transplantation

Simulated Treatment Comparison (STC) of Human Mesenchymal Stromal Cells (Remestemcel-L, REM) and Ruxolitinib (RUX) for Steroid-Refractory Acute Graft-Versus-Host Disease (SR aGVHD) Pediatric Patients

Targeting Transcriptional Co-Activator PGC-1a for the Treatment of Sickle Cell Disease

Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient

Long-Term Outcome of Children with Acute Leukemia (AL) Given Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT)

Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Regulating Transcriptional Co-Activator PGC-1α for the Treatment of Sickle Cell Disease

Reduced Toxicity Conditioning Is Better Tolerated but Has Higher Graft Failure Compared to Myeloablative Conditioning in Children with Inherited Metabolic Disorders

Hyper-CVAD Plus Ofatumumab As Frontline Therapy in CD20+ Acute Lymphoblastic Leukemia: Updated Results of a Phase II Trial

Nicord Single Unit Expanded Umbilical Cord Blood Transplantation: Final Results of a Multicenter Phase I/ II Trial

Adoptive Immunotherapy with Cord Blood (CB) Grafts Targeting Shared Inherited Paternal Antigens (IPA) and/or Non-Inherited Maternal Antigens (NIMA) during Induction Treatment for High Risk Myeloid Malignancies: Safety and Preliminary Results

Blinatumomab in B-Cell Acute Lymphoblastic Leukemia with Positive Minimal Residual Disease: Initial Results of a Phase II Trial

High-Exposure, Targeted Daily Busulfan and Fludarabine-Based Conditioning for Children Undergoing Hematopoietic Stem Cell Transplantation for Inherited Metabolic Disorders: Outcomes at a Single Center

The Changing Patterns of Graft Failure in MPS1H, Hurler Syndrome: A Review of 30-Years Experience

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Banked, GMP Grade Third Party T-Cell Lines Specific for CMVpp65 Epitopes Presented By Certain Prevalent HLA Alleles More Consistently Clear CMV Infections in a Genetically Heterogeneous Population of HSCT Recipients

Transient Bcl-XL Overexpression in Donor Stem Cells Increases Efficacy of Hematopoietic Stem Cell Transplantation without Increasing the Risk of Leukemogenesis

Infectious Complications After Unrelated Donor Allogeneic Hematopoietic Cell Transplantation With Or Without Alemtuzumab Based In Vivo Lymphocyte Depletion

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning Leads To High Rates Of Long-Term Engraftment and Low Toxicity Enabling The Use Of Mismatched and Unrelated Donors For Transplantation In Haemoglobinopathies

The Effectiveness Of Cidofovir In Disseminated Adenovirus Infections After Pediatric HSCT Is Closely Related To Lymphocyte Reconstitution

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only